Health condition
VHL surveillance protocol
VHL surveillance follows a defined lifelong calendar - annual eye checks and metanephrines from early childhood, MRI of brain, spine and abdomen at set intervals from adolescence - designed to find each tumour type at its most treatable.
Why trust this guide
- 01
Editorial team
Written by our editorial team from the UK sources listed on each page.
- 02
Sourced from guidance
Checked against current NHS and UK specialist society guidance at the time of review.
- 03
Current for 2026
Reviewed on 2026-09-27 with the next review scheduled for 2027-09-27.
Key facts
The essentials at a glance.
Which gene and test confirm it, who should be tested in the family, and which specialist to see.
-
From early childhood: annual ophthalmology (dilated retinal examination) and annual plasma or urinary metanephrines
-
From adolescence: MRI of the brain and whole spine every 1-3 years
-
From mid-teens: abdominal MRI every 1-2 years for kidneys, pancreas and adrenals - MRI is preferred over CT to limit lifetime radiation
-
Audiology and targeted imaging if hearing symptoms suggest an endolymphatic sac tumour; protocols intensify around pregnancy
Understanding the condition
What it is and what happens next.
What causes it, how it is confirmed, and the testing and specialist routes available in the UK.
What it is and how it presents
The protocol's logic maps each organ's risk to a test and an age: retinal haemangioblastomas appear earliest, hence childhood eye checks; phaeochromocytomas can complicate anaesthesia and pregnancy, hence annual biochemistry before anything invasive; renal cancers become the dominant adult threat, hence regular abdominal MRI with intervention typically deferred until a lesion approaches 3 cm. Missing a cycle rarely causes harm - drifting out of the programme for years is what the natural history punishes.
Testing, surveillance and specialist care
In practice a genetics centre or VHL clinic acts as the scheduler, holding the recall list, adjusting intervals to individual findings and pulling results into one annual review; anyone whose surveillance has lapsed can simply be re-referred and restarted. Family members who have never been tested for the familial variant can be offered a single definitive test rather than a lifetime of scans they may not need. NHS clinical genetics services carry some of the longest waits in the health service, often many months for a first appointment, whereas private genetic testing and a specialist review can typically be arranged within around two weeks.
Seeing a specialist
Who to see, and how quickly you can be seen.
The specialist for this condition is usually a clinical geneticist coordinating a VHL surveillance programme. Your GP can refer you on the NHS, or you can arrange a private consultation directly.
A quiet reminder
This guide is for information, not medical advice.
Your GP knows your history and can tell you which parts apply to you. If in doubt, see them - and seek urgent care for any emergency symptoms.
Frequently asked
Common questions about VHL surveillance protocol.
Quick, plain-English answers to what people ask us most.
-
What is the VHL surveillance protocol?
It is a structured, lifelong programme of regular tests and imaging used to monitor people with Von Hippel-Lindau (VHL) disease for the various tumours and cysts the condition can cause across multiple organs.
-
Why does VHL disease need such extensive surveillance?
VHL disease can cause tumours in several different organs, including the eyes, brain and spinal cord, kidneys, adrenal glands and pancreas, so comprehensive, coordinated surveillance helps catch problems early across all these areas.
-
What does the surveillance protocol typically include?
It usually includes regular eye examinations, MRI of the brain and spine, kidney and abdominal imaging, blood or urine tests for adrenal tumours, and hearing assessments, with specific intervals depending on age and personal risk.
-
Is VHL disease dangerous without surveillance?
Yes, without regular monitoring, tumours can grow undetected and cause serious complications, including vision loss, neurological damage, or cancer spread, so lifelong surveillance is a cornerstone of managing the condition safely.
-
Can VHL-related tumours be treated?
Yes, many VHL-related tumours can be effectively treated, often with organ-preserving techniques, particularly when caught early through surveillance before they cause symptoms or complications.
-
How often does surveillance need to happen?
This varies by organ and age, but generally includes annual eye and abdominal imaging, with brain and spine MRI at slightly longer intervals, tailored by a specialist experienced in VHL disease.
-
How is the surveillance protocol coordinated?
It's best coordinated by a multidisciplinary team, often through a specialist VHL clinic, ensuring all the different types of surveillance are scheduled appropriately and results are reviewed together.
-
VHL surveillance vs standard cancer screening - what's the difference?
Standard population cancer screening targets specific, common cancers in the general population, while VHL surveillance is a personalised, more extensive, multi-organ programme specifically tailored to the pattern of tumours associated with this particular genetic condition.
-
When should I start VHL surveillance, and how quickly can this be arranged privately?
Surveillance typically starts in childhood or the teenage years for some tests and continues throughout life; NHS specialist genetics or VHL clinics coordinate this, while private specialists experienced in VHL can often provide initial assessment within about two weeks.